WOCKHARDT RECEIVES US FDA QUALIFIED INFECTIOUS DISEASE PRODUCT DESIGNATION FOR WCK 6777, A FIRST EVER ONCE-A-DAY SS-LACTAM ENHANCER CLASS ANTIBIOTIC
Investor Call Recording February 2023 <noscript><iframe title="Investor Call" width="525" height="295" src="https://www.youtube.com/embed/wcCnujrwwz8?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></noscript>
Wockhardt to restructure US business to save $12 million per year, sees debt pare down Wockhardt to restructure US business to save $12 million per year, sees debt pare down
